The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lefkoff Kyle since 2006.
The trader's CIK number is 1191818.
At the time of the last reporting, Lefkoff Kyle was the Director of Array Biopharma Inc. (stock ticker symbol ARRY).
Also see all insider trading activities at Array Biopharma Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | MGEN | 0 | $0 | 26,702 | $399,926 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | ARRY | 0 | $0 | 35,000 | $725,480 | 25,000 | $261,750 |
| 2018 | ARRY | 0 | $0 | 100,000 | $1,723,000 | 105,000 | $513,750 |
| 2017 | ARRY | 0 | $0 | 83,865 | $879,828 | 95,000 | $709,575 |
| 2016 | ARRY | 0 | $0 | 0 | $0 | 5,000 | $29,150 |
| 2015 | ARRY | 0 | $0 | 70,000 | $560,070 | 70,000 | $193,900 |
| 2011 | ARRY | 5,000 | $11,100 | 0 | $0 | 0 | $0 |
| 2010 | ARRY | 4,000 | $14,840 | 10,000 | $32,730 | 0 | $0 |
| 2008 | ARRY | 8,000 | $36,750 | 0 | $0 | 0 | $0 |
| 2006 | ARRY | 0 | $0 | 62,000 | $701,702 | 0 | $0 |
1. Miragen Therapeutics, Inc. (MGEN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-09 | MGEN | Sale | 2,500 | 14.38 | 35,962 |
| 2017-03-10 | MGEN | Sale | 3,300 | 14.31 | 47,229 |
| 2017-03-06 | MGEN | Sale | 10,000 | 15.98 | 159,770 |
| 2017-03-08 | MGEN | Sale | 5,000 | 14.70 | 73,515 |
| 2017-02-22 | MGEN | Sale | 4,102 | 14.36 | 58,884 |
| 2017-02-23 | MGEN | Sale | 1,800 | 13.65 | 24,566 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-06 | ARRY | Option Ex | 25,000 | 10.47 | 261,750 |
| 2019-02-06 | ARRY | Sale | 35,000 | 20.73 | 725,480 |
| 2018-10-26 | ARRY | Option Ex | 5,000 | .00 | 0 |
| 2018-07-06 | ARRY | Option Ex | 50,000 | 5.54 | 277,000 |
| 2018-07-06 | ARRY | Sale | 50,000 | 17.45 | 872,500 |
| 2018-02-09 | ARRY | Option Ex | 50,000 | 4.74 | 236,750 |
| 2018-02-09 | ARRY | Sale | 50,000 | 17.01 | 850,500 |
| 2017-10-27 | ARRY | Option Ex | 5,000 | 10.47 | 52,350 |
| 2017-09-29 | ARRY | Option Ex | 45,000 | 10.58 | 476,100 |
| 2017-09-29 | ARRY | Sale | 38,865 | 12.31 | 478,428 |
| 2017-03-31 | ARRY | Sale | 45,000 | 8.92 | 401,400 |
| 2017-03-31 | ARRY | Option Ex | 45,000 | 4.03 | 181,125 |
| 2016-10-29 | ARRY | Option Ex | 5,000 | 5.83 | 29,150 |
| 2015-03-03 | ARRY | Option Ex | 70,000 | 2.77 | 193,900 |
| 2015-03-03 | ARRY | Sale | 70,000 | 8.00 | 560,070 |
| 2011-08-11 | ARRY | Buy | 5,000 | 2.22 | 11,100 |
| 2010-11-18 | ARRY | Sale | 2,000 | 3.17 | 6,340 |
| 2010-11-17 | ARRY | Sale | 3,000 | 3.28 | 9,840 |
| 2010-11-16 | ARRY | Sale | 5,000 | 3.31 | 16,550 |
| 2010-05-07 | ARRY | Buy | 4,000 | 3.71 | 14,840 |
| 2008-11-13 | ARRY | Buy | 3,000 | 3.27 | 9,825 |
| 2008-03-10 | ARRY | Buy | 5,000 | 5.38 | 26,925 |
| 2006-11-09 | ARRY | Sale | 51,000 | 11.80 | 601,800 |
| 2006-02-21 | ARRY | Sale | 11,000 | 9.08 | 99,902 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lefkoff Kyle (Director of Array Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.